A newly FDA-approved drug for narcolepsy is attracting attention for its potential applications beyond treating the sleep disorder, according to a recent briefing by *Nature* staff. The discussion also highlighted advancements in the creation of long-lived human brain organoids.
The FDA recently approved a drug for narcolepsy, and *Nature* staff are now discussing how it could unlock a host of novel brain therapies. The briefing, published online on August 21, 2026, details the potential for the drug to be repurposed for other neurological conditions. The specific mechanism by which this could occur wasn't detailed in the source.
Alongside the drug discussion, *Nature* staff also reported on the development of the longest-lived human brain organoids to date. These miniature, lab-grown brains are increasingly used to study brain development and disease. The development of these organoids, combined with the potential of the new narcolepsy drug, suggests promising avenues for future brain research and therapeutic development.
Read the original coverage
💬 Comments
📜 Comment Policy